Cervical cancer Doctors Abroad — Page 3

Professor Dan Grisaro is a leading specialist in gynecological cancer, with a focus on cervical cancer research and targeted therapies.

• Senior physician in gynecological oncology at Sourasky Medical Center
• Head of obstetrics and gynecology department at Sourasky
• Specialized in gynecologic oncology at the University of Toronto
• Author of 83 published scientific articles
• Member of multiple international gynecologic oncology societies

Dr. Topcu specializes in gynecological cancers, including cervical cancer, with training at top international centers like MD Anderson and Sunnybrook Odette.

• Board-certified in medical oncology with 18 years of experience of experience
• Trained in breast cancer at Sunnybrook Odette Cancer Center
• Works at Valued Med Hub Hospitals

Dr. Rabin specializes in treating tumors of the female reproductive system, coordinating patient care at Sheba Hospital.

• Completed residency in general oncology and radiotherapy at Sheba Hospital
• Fellowship at Anderson Cancer Center, Houston
• Recognized as best hospital employee in 2007
• Member of Israel Society of Oncology and Clinical Radiotherapy

Prof. Wolfgang Köstler is a leading Austrian oncologist specializing in gynecologic cancers, with over 22 years of experience of experience in targeted therapies and personalized medicine.

• Associate Professor at Medical University of Vienna
• Deputy Head of Clinical Division of Oncology
• Expert in biomarker development and tumor biology
• Senior consultant at Wiener Privatklinik

Associate Professor Dr. Yusuf Acikgoz brings international oncology experience from Ohio State University to Lokman Hekim University Ankara Hospital.

• Specializes in Medical Oncology with 10 years of experience of focused practice
• Participated in Phase III clinical trials for advanced cancer treatments
• Trained at prestigious institutions including Health Sciences University
• Member of American Society of Clinical Oncology (ASCO)
• Certified in Good Clinical Practice and human subjects research

Specializes in comprehensive tumor treatments at the certified interdisciplinary cancer center BKZ Solingen, blending cutting-edge therapies with molecular diagnostics.

• Board-certified in haematology, oncology, and immunology
• Expert in chemotherapy, immunotherapy, and targeted therapies
• Active member of the American Association for Cancer Research
• Leads molecular biology research for innovative cancer treatments
• Chief Physician at a certified cancer center

Dr. Ozatli specializes in treating breast, lung, and gastrointestinal cancers at Istinye University Liv Hospital Bahcesehir.

• Internal Medicine Specialist with diverse experience in oncology departments
• Expert in breast, lung, and gastrointestinal cancers
• Promoted to Associate Professor in 2016
• Member of professional oncology societies

Professor Keil specializes in diagnostic and interventional radiology, focusing on advanced imaging for cervical cancer at Medical Center in Solingen.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Head of Diagnostic and Interventional Radiology at Academic Hospital Solingen
• Expert in MRI, CT, and ultrasound for precise diagnostics
• Trained under renowned radiologists in Germany

49 years of experience in immunology with a focus on virotherapy – Dr. Jaunalksne brings cutting-edge immunological approaches to cervical cancer treatment at Pallas Clinic.

• Head of Clinical Immunology Center at Pauls Stradins Clinical University Hospital
• Specializes in virotherapy – a novel field in immunology
• Graduate of Riga Medical Institute with internship in Internal Medicine

Professor Cemil Bilir specializes in cervical cancer treatment with 21 years of experience of medical oncology experience, currently at VM Medical Park Pendik Hospital.

• Board-certified in medical oncology with subspecialty training
• Member of ASCO, ESMO, and TTOD – leading oncology societies
• Fellowship-trained at Cleveland Clinic and Northeastern University
• Professor at Sakarya University Faculty of Medicine

Dr. Séverine Iborra specializes in gynecological oncology with certifications in oncological diagnostics and therapy. She leads the Department of Gynecology and Obstetrics at Städtisches Klinikum Solingen.

• Certified in Gynecological Oncology and Special Obstetrics
• Expert in minimally invasive treatments including laparoscopy and Da Vinci robotic system
• Active member of leading German medical societies in gynecology
• Extensive research and publications in molecular oncology

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Nail Paksoy specializes in cervical cancer treatment at Medipol Bahçelievler Hospital, with extensive research and clinical trial experience.

• ESMO Board Certified in Medical Oncology
• Participated in multiple international clinical trials for cancer treatments
• Published numerous articles on oncology in peer-reviewed journals

Dr. Ercan Ozden specializes in cervical cancer treatment with over 27 years of experience of medical experience, trained at Istanbul University's prestigious Cerrahpaşa Faculty of Medicine.

• Completed Medical Oncology subspecialty at Kocaeli University – focused training in cancer treatment
• Extensive experience across multiple hospitals, handling diverse oncology cases
• Graduate of Cerrahpaşa's English Medical Program

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Professor Kyzas specializes in head and neck surgical oncology, with a focus on microvascular free tissue transfer and 3D personalized planning for reconstructive surgery.

• Trained in Oral and Maxillofacial Surgery at top UK teaching hospitals
• Principal Investigator for international trials on Transoral Laser resection
• Recipient of the prestigious Bronze National Clinical Excellence Award
• Editor in Chief of the British Journal of Oral and Maxillofacial Surgery
• Clinical Director for cancer services covering over 1 million people